HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of intrafascial and non-intrafascial radical prostatectomy for low risk localized prostate cancer.

Abstract
In this meta-analysis study, we compared the oncological and functional outcomes of intrafascial radical prostatectomy (IFRP) with non-intrafascial radical prostatectomy (NIFRP) in the treatment of patients with low risk localized prostate cancer (PCa). Relevant articles were identified by searching PubMed, EMBASE, Cochrane Library, Ovid, and the ISI Web of Knowledge databases. A total of 2096 patients were included from 7 eligible studies. Results of the pooled data showed that the oncological outcomes including gleason score, positive surgical margin and biochemical free survival rates were similar between the two groups. IFRP was superior to NIFRP with lower postoperative complication rates (RR 0.57, 95% CI 0.38, 0.85, p = 0.006), higher continence rates at 3 months post-operation (RR: 1.14; 95% CI, 1.04, 1.26; p = 0.006), and higher potency rates at 6 months (RR: 1.53; 95% CI, 1.07, 2.18; p = 0.02) and 12 months post-operation (RR: 1.38; 95% CI, 1.11, 1.73; p = 0.005). Additionally, there was a tendency towards higher potency rate in patients ≤65 years old compared with patients >65 years old after IFRP. Overall, these findings suggest that IFRP in young patients with low risk localized PCa had less postoperative complications, shortened time to return to continence and improved potency rate without compromising complete tumor control.
AuthorsZhankui Zhao, Haizhou Zhu, Honglian Yu, Qingsheng Kong, Chengjuan Fan, Lin Meng, Chuanxin Liu, Xiegang Ding
JournalScientific reports (Sci Rep) Vol. 7 Issue 1 Pg. 17604 (12 14 2017) ISSN: 2045-2322 [Electronic] England
PMID29242503 (Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't)
Topics
  • Aged
  • Erectile Dysfunction (etiology)
  • Humans
  • Laparoscopy (adverse effects)
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Postoperative Complications (pathology)
  • Postoperative Period
  • Prostate (pathology)
  • Prostatectomy (adverse effects, methods)
  • Prostatic Neoplasms (pathology, surgery)
  • Seminal Vesicles (pathology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: